Search research articles
Contact Us
Filters
Showing results (1-10 of 35) with videos related to
Page
of 4
Sort By:
European Journal of Immunology
|
October 16, 2004
Commentary: Priming of alloreactive T cells--where does it happen?
Dela Golshayan, Robert Lechler
Current Opinion in Organ Transplantation
|
July 10, 2010
Adoptive regulatory T cell therapy: challenges in clinical transplantation
Niloufar Safinia, Pervinder Sagoo, Robert Lechler, et al.
Lancet (London, England)
|
June 1, 2017
Strategies for long-term preservation of kidney graft function
Thomas Wekerle, Dorry Segev, Robert Lechler, et al.
Journal of Tissue Engineering and Regenerative Medicine
|
September 29, 2011
Placenta-derived MSCs are partially immunogenic and less immunomodulatory than bone marrow-derived MSCs
H Fazekasova, Robert Lechler, Kelly Langford, et al.
Xenotransplantation
|
August 24, 2006
NK-cell-dependent acute xenograft rejection in the mouse heart-to-rat model
Daxin Chen, Michele Weber, Robert Lechler, et al.
Blood
|
November 16, 2002
Antigen presentation by mouse CD4+ T cells involving acquired MHC class II:peptide complexes: another mechanism to limit clonal expansion?
Julia Y S Tsang, Jian Guo Chai, Robert Lechler
Biochemical Society Transactions
|
April 13, 2016
Antigen-specificity using chimeric antigen receptors: the future of regulatory T-cell therapy?
Dominic Boardman, John Maher, Robert Lechler, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 7, 2009
Superantigen-activated regulatory T cells inhibit the migration of innate immune cells and the differentiation of naive T cells
Yakup Tanriver, Alfonso Martín-Fontecha, Kulachelvy Ratnasothy, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 20, 2010
Targeting MHC class I monomers to dendritic cells inhibits the indirect pathway of allorecognition and the production of IgG alloantibodies leading to long-term allograft survival
Yakup Tanriver, Kulachelvy Ratnasothy, R Pat Bucy, et al.
International Immunopharmacology
|
January 16, 2007
Aspirin modified dendritic cells are potent inducers of allo-specific regulatory T-cells
Matthew Buckland, Charlotte Jago, Henrieta Fazekesova, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 35) with videos related to
Sort By:
Page
of 4
European Journal of Immunology
|
October 16, 2004
Commentary: Priming of alloreactive T cells--where does it happen?
Dela Golshayan, Robert Lechler
Current Opinion in Organ Transplantation
|
July 10, 2010
Adoptive regulatory T cell therapy: challenges in clinical transplantation
Niloufar Safinia, Pervinder Sagoo, Robert Lechler, et al.
Lancet (London, England)
|
June 1, 2017
Strategies for long-term preservation of kidney graft function
Thomas Wekerle, Dorry Segev, Robert Lechler, et al.
Journal of Tissue Engineering and Regenerative Medicine
|
September 29, 2011
Placenta-derived MSCs are partially immunogenic and less immunomodulatory than bone marrow-derived MSCs
H Fazekasova, Robert Lechler, Kelly Langford, et al.
Xenotransplantation
|
August 24, 2006
NK-cell-dependent acute xenograft rejection in the mouse heart-to-rat model
Daxin Chen, Michele Weber, Robert Lechler, et al.
Blood
|
November 16, 2002
Antigen presentation by mouse CD4+ T cells involving acquired MHC class II:peptide complexes: another mechanism to limit clonal expansion?
Julia Y S Tsang, Jian Guo Chai, Robert Lechler
Biochemical Society Transactions
|
April 13, 2016
Antigen-specificity using chimeric antigen receptors: the future of regulatory T-cell therapy?
Dominic Boardman, John Maher, Robert Lechler, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 7, 2009
Superantigen-activated regulatory T cells inhibit the migration of innate immune cells and the differentiation of naive T cells
Yakup Tanriver, Alfonso Martín-Fontecha, Kulachelvy Ratnasothy, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 20, 2010
Targeting MHC class I monomers to dendritic cells inhibits the indirect pathway of allorecognition and the production of IgG alloantibodies leading to long-term allograft survival
Yakup Tanriver, Kulachelvy Ratnasothy, R Pat Bucy, et al.
International Immunopharmacology
|
January 16, 2007
Aspirin modified dendritic cells are potent inducers of allo-specific regulatory T-cells
Matthew Buckland, Charlotte Jago, Henrieta Fazekesova, et al.
Page
of 4